Table 1.
Extract | Doses | Model of study | Effects | Ref. |
---|---|---|---|---|
F. szowitsiana methanolic E. | 10, 40 and 160 μg/ml | PHA-stimulated human T lymphocytes | Decreased IL-6 and TNF-α levels and attenuated the overproduction of inflammatory markers | (46) |
F. assa-foetida Oleo Gum Resin | 10 and 20 mg/kg, IP injection | Carrageenan-induced mice paw edema, hot plate test | Induced anti-nociception and inhibited lipoxygenase activity | (23) |
F. assafoetida seed’s essential oil of | 2.5, 5, and 10 mg/kg | Acetic acid-induced writhing tests in mice, hot plate tests. | Induced anti-nociception and showed anti-inflammatory activities | (24) |
F. assafoetida Methanol E. | 6-321 μg/mL | PTZ-induced seizures in mice | Cytotoxic activity | (25) |
F. szowitsiana hydroalcoholic E. | 50, 100, 200, 400 mg/kg, IP injection | Formalin-induced inflammation in Wistar rats | Reduced inflammation in a dose-dependent manner, mediated pain by the opioid system | (27) |
F. gummosa seed and root acetone E. | 200, 300, 400, and 500 mg/kg, IP injection | Acute and chronic pain in mice and rat | Showed anti-inflammatory effects | (29) |
F. hermonis | 25 μg/mL | In vitro study of pathogenic bacteria (Agrobacterium tumefaciens, Erwinia sp., Klebsiella pneumonia, and Pseudomonas aeruginosa) | Showed antibacterial and anti-inflammatory effects | (30) |
F, sinkiangen E. | 0.25 mg/mL | BV-2 microglial cells | Reduce IL-6, TNF-α, and IL-1β | (31) |
PHA: phytohemagglutinin, IP: intraperitoneal, STZ: Streptozotocin, IL-6: interleukin 6, TNF- α: tumor necrosis factor-alpha, E: extract